Uniunea Europeană - română - EMA (European Medicines Agency)

swedish orphan biovitrum ab (publ) - pegcetacoplan - hemoglobinurie, paroxismal - imunosupresoare - aspaveli is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh) who are anaemic after treatment with a c5 inhibitor for at least 3 months.

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

swedish orphan biovitrum ab (publ) - suedia - pegcetacoplanum - sol. perf. - 54mg/ml - imunosupresoare imunosupresoare selective